It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center (AUBMC) in a hybrid format from the Daniel ACC Building Ground Floor Conference Rooms. Speakers and attendees in Lebanon were present...
By Khalid El Bairi, MDOn a beautiful morning in early October 2022, I received a WhatsApp message from an enthusiastic young professor of pharmacy, Dr. Faisal Gulzar, who invited me to deliver presentations in a country very far from my home in Morocco—Pakistan! A country that I've never visited and that I mostly know...
The new findings indicate frequent aspirin use provides a protective effect against nonmucinous ovarian cancer, regardless of a person's genetic susceptibility. Medscape Medical News
Renewed calls for all women to consider having their fallopian tubes removed once they have finished with childbearing come from the Ovarian Cancer Research Alliance. Medscape Medical News
The expanded indication for pafolacianine (Cytalux) follows an initial approval in November 2021 for use in patients with ovarian cancer. Medscape Medical News
Using the Breast Cancer Index earlier could identify premenopausal HR+ breast cancer patients who benefit from ovarian function suppression, suggests analysis. Medscape Medical News
A global study of the microscopic patterns of cell growth in samples taken from women with this rare form of ovarian cancer may lead to treatment changes for some. Medscape Medical News
Zejula, Lynparza, and Rubraca have been voluntarily withdrawn for late-line ovarian cancer treatment indications over concerns surrounding an increased risk for death. Medscape Medical News
Despite guidelines advising against intensive end-of-life care, many women with terminal ovarian cancer receive an aggressive intervention. Medscape Medical News
Time Management Tips
29.8 ° C